- £43.64m
- £44.94m
- £938.20m
- 46
- 86
- 61
- 74
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,063 | 928 | 943 | 941 | 938 |
Cost of Revenue | |||||
Gross Profit | 87.5 | 74.6 | 82.8 | 83.2 | 80.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,102 | 975 | 940 | 936 | 942 |
Operating Profit | -39.4 | -47.5 | 2.3 | 4.3 | -3.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -44.4 | -51.6 | -0.1 | 1.9 | -7.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -41 | -48.5 | 1.6 | 3.8 | -8.4 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -44 | -52.7 | 1.2 | 3.8 | -11 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -44 | -52.7 | 1.2 | 3.8 | -11 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.136 | -0.061 | 0.025 | 0.022 | -0.009 |
Dividends per Share |